News for 'drug manufacturing'

UK's new antibody treatment against Covid may work against Omicron

UK's new antibody treatment against Covid may work against Omicron

Rediff.com2 Dec 2021

The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron.

India's richest club sees nine new entrants; Ambani still No 1

India's richest club sees nine new entrants; Ambani still No 1

Rediff.com9 Oct 2020

Half of the nation's 100 richest saw gains rising a collective 14% to $517.5 billion, says Forbes. Forbes released 2020's top 100 richest Indians on Thursday, which included newcomers, Sanjeev Bikhchandani, co-founder of Info Edge (India), who owns popular job and property websites; siblings Nithin and Nikhil Kamath, co-founders of discount stock brokerage Zerodha Broking, and three specialty chemicals producers - Vinod Saraf, founder of Vinati Organics, Arun Bharat Ram, the patriarch of SRF, and brothers Chandrakant and Rajendra Gogri of Aarti Industries. Other newcomers included Delhi-based brothers Ramesh Kumar and Mukand Lal Dua of Relaxo Footwears, which owns affordable footwear brands; dairyman, R G Chandramogan of Hatsun Agro; Premchand Godha, who chairs IPCA Laboratories, manufacturing formulations, bulk drugs and drug intermediates; G Rajendran, founder of jewellery chain, GRT Jewellers.

Bombay HC: Cannabis plant can't be considered 'ganja' if...

Bombay HC: Cannabis plant can't be considered 'ganja' if...

Rediff.com4 Sep 2022

A seized cannabis plant without flowering or fruiting tops does not fall under the purview of 'ganja', the Bombay high court has ruled while granting pre-arrest bail to a man accused of possessing commercial quantity of the narcotic substance.

WHO meet next week to discuss Covaxin approval

WHO meet next week to discuss Covaxin approval

Rediff.com18 Oct 2021

The World Health Organisation's technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) of Covaxin, a vaccine developed by Hyderabad-based Bharat Biotech protecting against COVID-19, the global health agency's chief scientist said.

Serum Inst to launch first indigenous vaccine against pneumonia

Serum Inst to launch first indigenous vaccine against pneumonia

Rediff.com24 Dec 2020

According to the sources, the vaccine will be much more affordable than existing ones manufactured by two foreign companies. India's drug regulator in July had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the phase 1, 2 and 3 clinical trial data submitted by the Pune-based firm.

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

Serum Institute chief Adar Poonawalla takes Covishield jab

Serum Institute chief Adar Poonawalla takes Covishield jab

Rediff.com16 Jan 2021

Poonawalla wished the country and Prime Minister Narendra Modi success for the vaccination programme.

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Stop advertising Covid 'medicines', give details: Govt to Patanjali

Rediff.com24 Jun 2020

Ramdev's herbal medicine company Patanjali Ayurved has launched 'Coronil tablet and Swasari vati' medicines claiming they can cure the highly contagious disease within seven days.

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

CoWIN portal in Hindi, other languages from next week: Govt

CoWIN portal in Hindi, other languages from next week: Govt

Rediff.com17 May 2021

The CoWIN portal will be made available in Hindi and 14 regional languages by next week, while 17 more laboratories will be added to the INSACOG network to monitor the variants of COVID-19, the health ministry said on Monday.

Bharat Biotech to rectify issues with Covaxin raised by WHO

Bharat Biotech to rectify issues with Covaxin raised by WHO

Rediff.com5 Apr 2022

According to sources close to ANI, "Bharat Biotech has informed Union health ministry that it will rectify the issues pointed out by WHO in 15 to 20 days." "World Health Organisation (WHO)'s suspension is not related to safety or efficacy issues but limited only to supply for United Nations agencies."

Centre to SC: 122 cr doses needed to inoculate 59 cr youth

Centre to SC: 122 cr doses needed to inoculate 59 cr youth

Rediff.com2 May 2021

The Centre told the apex court that it has fast tracked the emergency approvals for foreign produced COVID-19 vaccines that have been granted approval in other countries

Pharma industry wants Budget to offer tax clarity

Pharma industry wants Budget to offer tax clarity

Rediff.com24 Jan 2017

Pharma body wants all excisable goods used for R&D purposes should be exempted from central excise duty.

Traders seek Army's help to distribute medicines

Traders seek Army's help to distribute medicines

Rediff.com31 Mar 2020

The situation is severe in North India as most of the logistics operation was manned by migrant labourers from Uttar Pradesh and Bihar. The problem with manpower is not only in courier and delivery services, but also at a shop level.

Serum Inst gets DGCI notice over continuation of vaccine trial

Serum Inst gets DGCI notice over continuation of vaccine trial

Rediff.com9 Sep 2020

The show-cause notice was issued following reports that human trials of the most promising COVID-19 vaccine candidate, being developed by the University of Oxford, have been put on hold after a United Kingdom participant had an adverse reaction to it.

Serum Institute gets nod to resume vaccine trial in India

Serum Institute gets nod to resume vaccine trial in India

Rediff.com16 Sep 2020

SII has been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

DCGI orders Serum to suspend recruitment for COVID-19 vaccine trials

Rediff.com11 Sep 2020

The DCGI also directed Serum Institute of India to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.

Clean chit for J&J's baby shampoo

Clean chit for J&J's baby shampoo

Rediff.com10 Jun 2019

The outcome reaffirms the company's own testing and the long-standing assurance it gave that its baby shampoo does not contain formaldehyde or any formaldehyde-releasing ingredients, J&J said.

Huge difference between pre- and post-2014 India, Modi tells diaspora in Bali

Huge difference between pre- and post-2014 India, Modi tells diaspora in Bali

Rediff.com15 Nov 2022

Prime Minister Narendra Modi on Tuesday asserted that there is a "huge difference" between pre- and post-2014 India, saying the country is now moving ahead at an "unprecedented speed and scale" as he showcased the achievements of his term in power to the Indian diaspora in Indonesia.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

Serum Institute to begin trials of COVID-19 vaccine in Mumbai, Pune

Serum Institute to begin trials of COVID-19 vaccine in Mumbai, Pune

Rediff.com23 Jul 2020

There are a number of trial sites across both Mumbai and Pune that we have shortlisted, as these cities have many hotspots, which will help us understand the efficacy of the vaccine, the company's chief executive Adar Poonawalla said.

Highlights of Union Budget 2022-23

Highlights of Union Budget 2022-23

Rediff.com1 Feb 2022

Finance Minister Nirmala Sitharaman presents her fourth Budget in Lok Sabha on Tuesday.

India gets 3rd vaccine as DCGI approves Sputnik V

India gets 3rd vaccine as DCGI approves Sputnik V

Rediff.com13 Apr 2021

According to sources, around 10 crore doses of the Sputnik V vaccine is likely to be imported for emergency use in the country in the next six to seven months.

'Won't be forgotten': Trump thanks India for hydroxychloroquine

'Won't be forgotten': Trump thanks India for hydroxychloroquine

Rediff.com9 Apr 2020

'I want to thank Prime Minister Modi of India for allowing us to have what we requested for the problem arose and he was terrific. We will remember it'

All above 18 years to get COVID-19 vaccine from May 1

All above 18 years to get COVID-19 vaccine from May 1

Rediff.com19 Apr 2021

Based on this price, state governments, private hospitals, industrial establishments, etc would be able to procure vaccine doses from the manufacturers.

Pfizer Covid vaccine gets US experts' nod

Pfizer Covid vaccine gets US experts' nod

Rediff.com11 Dec 2020

The Pfizer vaccine has already been approved for the public in the United Kingdom and, Canada.

States to get 7 lakh Covid vaccine doses in 3 days: Centre

States to get 7 lakh Covid vaccine doses in 3 days: Centre

Rediff.com11 May 2021

More than 90 lakh Covid-19 vaccine doses are still available with states and Union territories which will receive over 7 lakh additional doses in the next three days, the Union health ministry said on Tuesday.

For India's cannabis industry the grass could be greener

For India's cannabis industry the grass could be greener

Rediff.com9 Mar 2021

'The government wants farmers to diversify from rice and wheat, and create another green revolution. Cannabis can play a big part in that'

Why Chinese imports are likely to continue

Why Chinese imports are likely to continue

Rediff.com26 Jun 2020

Indian auto and pharma industries import several critical components and raw materials from China.

USFDA issues import alert on Ranbaxy's Mohali plant

USFDA issues import alert on Ranbaxy's Mohali plant

Rediff.com16 Sep 2013

While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.

Patanjali takes a u-turn, says never claimed Coronil can cure Covid

Patanjali takes a u-turn, says never claimed Coronil can cure Covid

Rediff.com30 Jun 2020

Patanjali Ayurved, in collaboration with NIMS University, launched Coronil and Shwasari Vati, claiming to cure corona patients.

India approves Oxford's, Bharat Biotech's vaccines for emergency use

India approves Oxford's, Bharat Biotech's vaccines for emergency use

Rediff.com3 Jan 2021

The approval by the Drugs Controller General of India (DCGI) was given on the basis of recommendations submitted by a COVID-19 subject expert committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO).

PM holds meet with teams involved in developing COVID vaccine

PM holds meet with teams involved in developing COVID vaccine

Rediff.com30 Nov 2020

The teams were from Gennova Biopharmaceuticals Ltd Pune, Biological E Ltd Hyderabad and Dr Reddys Laboratories Ltd Hyderabad.

Ranbaxy 'systematically violated' norms: Whistleblower

Ranbaxy 'systematically violated' norms: Whistleblower

Rediff.com14 May 2013

The generic drugs at issue were manufactured at Ranbaxy's facilities in Paonta Sahib and Dewas in India and included acne drug Sotret, epilepsy and nerve pain drug gabapentin and antibiotic ciprofloxacin.

'After Covid, demand will be back with a vengeance'

'After Covid, demand will be back with a vengeance'

Rediff.com11 Dec 2020

'When there is unlocking, there is demand revival.' 'This is going to be the main growth engine in this kind of an economic scenario.'

Vaccine registration for those above 18 to open from April 28

Vaccine registration for those above 18 to open from April 28

Rediff.com22 Apr 2021

The central government had announced that the vaccination for those above 18 years will begin across the country from May 1 as part of the third phase of the inoculation drive.

Drug firms bet big on SEZs

Drug firms bet big on SEZs

Rediff.com12 Apr 2006

Why finding COVID-19 vaccine won't be enough to end pandemic

Why finding COVID-19 vaccine won't be enough to end pandemic

Rediff.com13 May 2020

Medical experts have warned that the volume of vaccine available to fight the coronavirus or SARS-CoV-2 in coming years is expected to fall far short of global demand, despite an unprecedented effort to manufacture billions of doses.

Over 1.82 cr jabs available with states, 4 lakh in pipeline: Centre

Over 1.82 cr jabs available with states, 4 lakh in pipeline: Centre

Rediff.com29 May 2021

More than 1.82 crore COVID-19 vaccine doses are available with states and union territories, and over 4 lakh will be received by them within the next three days, the Union health ministry said.

11 food, pharma organisations seek CBI inquiry against FSSAI

11 food, pharma organisations seek CBI inquiry against FSSAI

Rediff.com1 Oct 2015

As many as 11 industry bodies related to food and pharma sectors on Thursday alleged that the food regulator FSSAI has become "den of corruption" and demanded a CBI inquiry into the functioning of the authority, which shot to limelight over the Maggi issue.